Raphael Szalat | Profiles RNS

Raphael E. Szalat, MD, PhD

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Hematology & Oncology

MD, Université Paris-Sorbonne, Paris IV
PhD, Université Paris-Sorbonne, Paris IV

Pronouns: he/him/his

Websites

	LinkedIn
	Boston Medical Center Provider Profile
	Boston University School of Medicine
	Harvard Catalyst Profile
	myNCBI

ORCID : 0000-0002-6198-3405

I received my medical training at the University of Pierre and Marie Curie, in Paris, France. After Internal Medicine residency, I specialized in Immunology and plasma cell disorders including multiple myeloma and monoclonal gammopathies of clinical significance and became a clinical assistant professor in the department of Immuno-Hematology in Saint-Louis hospital, Paris. I next completed a PhD and post-doc in hematology studying genomics in Multiple Myeloma at the Dana-Farber Cancer Institute, Harvard Medical School in collaboration with La Sorbonne University, Paris and a clinical fellowship in Hematology and Oncology at the Boston University Medical Center. I am currently the multiple myeloma program director and the Stem Cell Transplant director at the Boston University Medical Center. My main interests are to develop myeloma clinical trials and to perform basic and translational research on multiple myeloma and other plasma cell disorders including AL amyloidosis and other monoclonal gammopathy of clinical significance.

Diversity, Equity, Inclusion and Accessibility

I am committed to promoting diversity and inclusion in academia and medicine. I have actively participated to all the Hematology and Medical Oncology section Diversity, Equity and Inclusions workshops. I participated to the LIFT Bystander Training for Microaggressions Workshops and to all other workshops proposed by our section. I am very attached to “medical” Justice and I am working on improving equal access to education, information and treatment of plasma cell disorders. To do so, I am leading the effort to develop a BU-CME interactive program addressing how to overcome barriers to effective treatment and enrollment in clinical trials of Afro-Americans and underserved patients.

BMC Research

64407564MMY3002
05/05/2023 - 05/04/2026 (PI)
Janssen Research and Development, LLC

TAK-573-1501: A Phase 1/2 Open-label Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Modakafusp Alfa (TAK-573) as a Single Agent in Patients With Relapsed Refractory Multiple Myeloma
11/30/2022 - 11/29/2025 (PI)
Takeda Pharmaceuticals

Molecular characterization and therapeutic targeting of Protein Kinase D 2 in t(4;14) Multiple Myeloma
05/01/2021 - 03/31/2024 (PI)
International Myeloma Society

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Szalat R, Anderson K, Munshi N. Role of minimal residual disease assessment in multiple myeloma. Haematologica. 2024 Feb 08.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 38328864

Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the Black Women's Health Study. Br J Cancer. 2024 Mar; 130(5):830-835.View Related Profiles.

Zirpoli, Gary
Palmer, Julie
Bertrand, Kimberly
Szalat, Raphael
Kataria, Yachana

PMID: 38212484; PMCID: PMC10912597; DOI: 10.1038/s41416-023-02571-w;

Bertrand KA, Szalat R. Deciphering racial disparities in multiple myeloma outcomes. Blood Adv. 2024 Jan 09; 8(1):234-235.View Related Profiles.

Bertrand, Kimberly
Szalat, Raphael

PMID: 38194241; PMCID: PMC10918417; DOI: 10.1182/bloodadvances.2023011457;

Samur MK, Szalat R, Munshi NC. Single-cell profiling in multiple myeloma: insights, problems, and promises. Blood. 2023 Jul 27; 142(4):313-324.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 37196627; PMCID: PMC10485379; DOI: 10.1182/blood.2022017145;

Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V. Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes. Haematologica. 2023 Jun 01; 108(6):1680-1684.View Related Profiles.

Staron, Andrew
Sloan, J.
Mendelson, Lisa
Szalat, Raphael
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 36546447; PMCID: PMC10230421; DOI: 10.3324/haematol.2022.282264;

Samur MK, Roncador M, Aktas Samur A, Fulciniti M, Bazarbachi AH, Szalat R, Shammas MA, Sperling AS, Richardson PG, Magrangeas F, Minvielle S, Perrot A, Corre J, Moreau P, Thakurta A, Parmigiani G, Anderson KC, Avet-Loiseau H, Munshi NC. High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma. Blood. 2023 Apr 06; 141(14):1724-1736.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 36603186; PMCID: PMC10273091; DOI: 10.1182/blood.2022017094;

Fillmore NR, Szalat RE, La J, Branch-Elliman W, Monach PA, Nguyen V, Samur MK, Brophy MT, Do NV, Munshi NC. Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study. Proc Natl Acad Sci U S A. 2022 Nov 16; 119(46):e2213783119.View Related Profiles.

La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Munshi, Nikhil C.
Szalat, Raphael
Branch-Elliman, Westyn

PMID: 36343242; PMCID: PMC9674225; DOI: 10.1073/pnas.2213783119;

Muchtar E, Dispenzieri A, Wisniowski B, Palladini G, Milani P, Merlini G, Schönland S, Veelken K, Hegenbart U, Geyer SM, Kumar SK, Kastritis E, Dimopoulos MA, Liedtke M, Witteles R, Sanchorawala V, Szalat R, Landau H, Petrlik E, Lentzsch S, Coltoff A, Bladé J, Cibeira MT, Cohen O, Foard D, Wechalekar A, Gertz MA. Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. J Clin Oncol. 2023 Mar 01; 41(7):1393-1403.View Related Profiles.

Szalat, Raphael
Sanchorawala, Vaishali

PMID: 36215675; PMCID: PMC10489422; DOI: 10.1200/JCO.22.00643;

Bertrand KA, Zirpoli G, Niharika Pillalamarri B, Szalat R, Palmer JR, Kataria Y. Prevalence of monoclonal gammopathy of undetermined significance in US black women. Am J Hematol. 2022 Sep; 97(9):E341-E343.View Related Profiles.

Zirpoli, Gary
Palmer, Julie
Bertrand, Kimberly
Szalat, Raphael
Kataria, Yachana

PMID: 35723873; PMCID: PMC9558112; DOI: 10.1002/ajh.26638;

Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles.

Staron, Andrew
Edwards, Camille
Gopal, Deepa
Ruberg, Frederick
Sloan, J.
Berk, John
Lau, K.H. Vincent
Mendelson, Lisa
Kaku, Michelle
Siddiqi, Omar
Szalat, Raphael
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35731907

Showing 10 of 54 results. Show More

Bazarbachi AH, Avet-Loiseau H, Szalat R, Samur AA, Hunter Z, Shammas M, Corre J, Fulciniti M, Anderson KC, Parmigiani G, Treon SP, Mohty M, Munshi NC, Samur MK. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM. Blood. 2021 11 18; 138(20):1980-1985.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael
Hunter, Zachary

PMID: 34792571; PMCID: PMC8602933; DOI: 10.1182/blood.2021011452;

Szalat RE, Gustine J, Sloan JM, Edwards CV, Sanchorawala V. Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. Am J Hematol. 2022 01 01; 97(1):79-89.View Related Profiles.

Edwards, Camille
Sloan, J.
Szalat, Raphael
Sanchorawala, Vaishali

PMID: 34739735

Fillmore NR, Cirstea D, Munjuluri A, Yameen H, Yellapragada SV, Do NV, Brophy MT, Szalat RE, Munshi NC. Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study. Blood Adv. 2021 09 28; 5(18):3511-3514.View Related Profiles.

Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Munshi, Nikhil C.
Szalat, Raphael

PMID: 34428278; PMCID: PMC8945588; DOI: 10.1182/bloodadvances.2020004001;

Ruiz-Heredia Y, Ortiz-Ruiz A, Samur MK, Garrido V, Rufian L, Sanchez R, Aguilar-Garrido P, Barrio S, Martín MA, Bolli N, Tai YT, Szalat R, Fulciniti M, Munshi N, Martínez-López J, Linares M, Gallardo M. Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma. Cancers (Basel). 2021 Jun 25; 13(13).View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 34202390; PMCID: PMC8268477; DOI: 10.3390/cancers13133189;

Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study. J Natl Cancer Inst. 2021 06 01; 113(6):691-698.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Munshi, Nikhil C.
Szalat, Raphael

PMID: 33031532; PMCID: PMC7665587; DOI: 10.1093/jnci/djaa159;

Hassan H, Szalat R. Genetic Predictors of Mortality in Patients with Multiple Myeloma. Appl Clin Genet. 2021; 14:241-254.View Related Profiles.

Hassan, Hamza
Szalat, Raphael

PMID: 33953598; PMCID: PMC8092627; DOI: 10.2147/TACG.S262866;

Acevedo J, Doros G, Szalat R, Sanchorawala V. Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 06; 21(6):425-426.View Related Profiles.

Doros, Gheorghe
Acevedo, Jose
Szalat, Raphael
Sanchorawala, Vaishali

PMID: 33622658

Szalat R, Sarosiek S, Havasi A, Brauneis D, Sloan JM, Sanchorawala V. Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia. 2021 03; 35(3):916-919.View Related Profiles.

Havasi, Andrea
Sloan, J.
Szalat, Raphael
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32737434

Samur MK, Aktas Samur A, Fulciniti M, Szalat R, Han T, Shammas M, Richardson P, Magrangeas F, Minvielle S, Corre J, Moreau P, Thakurta A, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC. Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group. J Clin Oncol. 2020 09 20; 38(27):3107-3118.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 32687451; PMCID: PMC7499613; DOI: 10.1200/JCO.20.00461;

Alagpulinsa DA, Szalat RE, Poznansky MC, Shmookler Reis RJ. Genomic Instability in Multiple Myeloma. Trends Cancer. 2020 10; 6(10):858-873. PMID: 32487486; DOI: 10.1016/j.trecan.2020.05.006;

Alagpulinsa DA, Kumar S, Talluri S, Nanjappa P, Buon L, Chakraborty C, Samur MK, Szalat R, Shammas MA, Munshi NC. Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma. Blood Adv. 2019 12 10; 3(23):3968-3972.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 31805191; PMCID: PMC6963244; DOI: 10.1182/bloodadvances.2019000181;

Rajkumar-Calkins AS, Szalat R, Dreze M, Khan I, Frazier Z, Reznichenkov E, Schnorenberg MR, Tsai YF, Nguyen H, Kochupurakkal B, D'Andrea AD, Shapiro GI, Lazaro JB, Mouw KW. Functional profiling of nucleotide Excision repair in breast cancer. DNA Repair (Amst). 2019 10; 82:102697. PMID: 31499327; PMCID: PMC6815104; DOI: 10.1016/j.dnarep.2019.102697;

Maura F, Bolli N, Angelopoulos N, Dawson KJ, Leongamornlert D, Martincorena I, Mitchell TJ, Fullam A, Gonzalez S, Szalat R, Abascal F, Rodriguez-Martin B, Samur MK, Glodzik D, Roncador M, Fulciniti M, Tai YT, Minvielle S, Magrangeas F, Moreau P, Corradini P, Anderson KC, Tubio JMC, Wedge DC, Gerstung M, Avet-Loiseau H, Munshi N, Campbell PJ. Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nat Commun. 2019 08 23; 10(1):3835.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 31444325; PMCID: PMC6707220; DOI: 10.1038/s41467-019-11680-1;

Szalat R, Munshi NC. Novel Agents in Multiple Myeloma. Cancer J. 2019 Jan/Feb; 25(1):45-53. PMID: 30694859; PMCID: PMC6589825; DOI: 10.1097/PPO.0000000000000355;

Fulciniti M, Lin CY, Samur MK, Lopez MA, Singh I, Lawlor MA, Szalat RE, Ott CJ, Avet-Loiseau H, Anderson KC, Young RA, Bradner JE, Munshi NC. Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma. Cell Rep. 2018 12 26; 25(13):3693-3705.e6.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 30590042; PMCID: PMC6407615; DOI: 10.1016/j.celrep.2018.12.016;

Bolli N, Maura F, Minvielle S, Gloznik D, Szalat R, Fullam A, Martincorena I, Dawson KJ, Samur MK, Zamora J, Tarpey P, Davies H, Fulciniti M, Shammas MA, Tai YT, Magrangeas F, Moreau P, Corradini P, Anderson K, Alexandrov L, Wedge DC, Avet-Loiseau H, Campbell P, Munshi N. Genomic patterns of progression in smoldering multiple myeloma. Nat Commun. 2018 08 22; 9(1):3363.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 30135448; PMCID: PMC6105687; DOI: 10.1038/s41467-018-05058-y;

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan G. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. 2019 01; 33(1):159-170.View Related Profiles.

Rozelle, Dan
Munshi, Nikhil C.
Szalat, Raphael

PMID: 29967379; PMCID: PMC6326953; DOI: 10.1038/s41375-018-0196-8;

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan GJ. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018 08 09; 132(6):587-597.View Related Profiles.

Rozelle, Dan
Munshi, Nikhil C.
Szalat, Raphael

PMID: 29884741; PMCID: PMC6097138; DOI: 10.1182/blood-2018-03-840132;

Samur MK, Minvielle S, Gulla A, Fulciniti M, Cleynen A, Aktas Samur A, Szalat R, Shammas M, Magrangeas F, Tai YT, Auclair D, Keats J, Richardson P, Attal M, Moreau P, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC. Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma. Leukemia. 2018 12; 32(12):2626-2635.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 29749396; PMCID: PMC6163089; DOI: 10.1038/s41375-018-0116-y;

Szalat R, Munshi NC. Diagnosis of Castleman Disease. Hematol Oncol Clin North Am. 2018 02; 32(1):53-64.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 29157619

Maura F, Petljak M, Lionetti M, Cifola I, Liang W, Pinatel E, Alexandrov LB, Fullam A, Martincorena I, Dawson KJ, Angelopoulos N, Samur MK, Szalat R, Zamora J, Tarpey P, Davies H, Corradini P, Anderson KC, Minvielle S, Neri A, Avet-Loiseau H, Keats J, Campbell PJ, Munshi NC, Bolli N. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. Leukemia. 2018 04; 32(4):1044-1048.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 29209044; PMCID: PMC5886048; DOI: 10.1038/leu.2017.345;

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E, Chretien ML, Anderson K, Minvielle S, Moreau P, Attal M, Parmigiani G, Corre J, Munshi N, Avet-Loiseau H. Expressed fusion gene landscape and its impact in multiple myeloma. Nat Commun. 2017 12 01; 8(1):1893.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 29196615; PMCID: PMC5711960; DOI: 10.1038/s41467-017-00638-w;

Boutboul D, Touzot F, Szalat R. Understanding therapeutic emergencies in acute hemolysis. Intensive Care Med. 2018 04; 44(4):482-485. PMID: 28871399; DOI: 10.1007/s00134-017-4918-6;

Szalat R, Samur MK, Fulciniti M, Lopez M, Nanjappa P, Cleynen A, Wen K, Kumar S, Perini T, Calkins AS, Reznichenko E, Chauhan D, Tai YT, Shammas MA, Anderson KC, Fermand JP, Arnulf B, Avet-Loiseau H, Lazaro JB, Munshi NC. Nucleotide excision repair is a potential therapeutic target in multiple myeloma. Leukemia. 2018 01; 32(1):111-119.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 28588253; PMCID: PMC5720937; DOI: 10.1038/leu.2017.182;

Vignon M, Placais L, Malphettes M, Bouaziz JD, Asli B, Bedossa P, Rivet J, Szalat R, Zagdanski AM, Rybojad M, Fermand JP, Baron M, Rautou PE, Arnulf B. Non-cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy. J Eur Acad Dermatol Venereol. 2017 Sep; 31(9):e403-e405. PMID: 28295661

Fulciniti M, Martinez-Lopez J, Senapedis W, Oliva S, Lakshmi Bandi R, Amodio N, Xu Y, Szalat R, Gulla A, Samur MK, Roccaro A, Linares M, Cea M, Baloglu E, Argueta C, Landesman Y, Shacham S, Liu S, Schenone M, Wu SL, Karger B, Prabhala R, Anderson KC, Munshi NC. Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma. Blood. 2017 04 20; 129(16):2233-2245.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 28096095; PMCID: PMC5399480; DOI: 10.1182/blood-2016-06-724831;

Jakubikova J, Cholujova D, Hideshima T, Gronesova P, Soltysova A, Harada T, Joo J, Kong SY, Szalat RE, Richardson PG, Munshi NC, Dorfman DM, Anderson KC. A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications. Oncotarget. 2016 Nov 22; 7(47):77326-77341.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 27764795; PMCID: PMC5357212; DOI: 10.18632/oncotarget.12643;

Szalat R, Avet-Loiseau H, Munshi NC. Gene Expression Profiles in Myeloma: Ready for the Real World? Clin Cancer Res. 2016 Nov 15; 22(22):5434-5442.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 28151711; PMCID: PMC5546147; DOI: 10.1158/1078-0432.CCR-16-0867;

AlGain M, Damade R, Aucouturier F, Rivet J, Jachiet M, Malphettes M, Hickman G, Szalat R, Saussine A, de Masson A, Petit A, Rybojad M, Bagot M, Arnulf B, Bouaziz JD. Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide. J Eur Acad Dermatol Venereol. 2017 Jan; 31(1):e38-e39. PMID: 27297832; DOI: 10.1111/jdv.13628;

Szalat R, Munshi NC. Corrigendum to "Genomic heterogeneity in multiple myeloma" [Curr. Opin. Genet. Dev. 30 (2015) 56-65]. Curr Opin Genet Dev. 2016 04; 37:158.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 27321239

AlGain M, Szalat R, Vignon-Pennamen MD, Malphettes M, Vignon M, de Masson A, Bagot M, Rybojad M, Asli B, Arnulf B, Bouaziz JD. A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma. J Eur Acad Dermatol Venereol. 2017 Jan; 31(1):e3-e5. PMID: 26810089

Szalat R, Munshi NC. Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches. Am Soc Clin Oncol Educ Book. 2016; 35:e442-8.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 27249752

Szalat R, Monsel G, Le Goff W, Battistella M, Bengouffa D, Schlageter MH, Bouaziz JD, Arnulf B, Vignon M, Lesnik P, Saussine A, Malphettes M, Lazareth A, Vignon-Pennamen MD, Bagot M, Brouet JC, Fermand JP, Rybojad M, Asli B. The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile. J Am Acad Dermatol. 2015 Nov; 73(5):809-20. PMID: 26365596

Cohen C, Royer B, Javaugue V, Szalat R, El Karoui K, Caulier A, Knebelmann B, Jaccard A, Chevret S, Touchard G, Fermand JP, Arnulf B, Bridoux F. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease. Kidney Int. 2015 Nov; 88(5):1135-43. PMID: 26176826; DOI: 10.1038/ki.2015.201;

Szalat R, Munshi NC. Genomic heterogeneity in multiple myeloma. Curr Opin Genet Dev. 2015 02; 30:56-65.View Related Profiles.

Munshi, Nikhil C.
Szalat, Raphael

PMID: 25982873

Malphettes M, Gérard L, Galicier L, Boutboul D, Asli B, Szalat R, Perlat A, Masseau A, Schleinitz N, Le Guenno G, Viallard JF, Bonnotte B, Thiercelin-Legrand MF, Sanhes L, Borie R, Georgin-Lavialle S, Fieschi C, Oksenhendler E. Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clin Infect Dis. 2015 Jul 15; 61(2):e13-9. PMID: 25828999

Harel S, Mohr M, Jahn I, Aucouturier F, Galicier L, Asli B, Malphettes M, Szalat R, Brouet JC, Lipsker D, Fermand JP. Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases. Br J Haematol. 2015 Mar; 168(5):671-8. PMID: 25363150

Fouquet G, Hebraud B, Garciaz S, Stoppa AM, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Touzeau C, Tessoulin B, Fermand JP, Facon T, Attal M, Loiseau HA, Moreau P, Leleu X. Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation. J Cancer. 2014; 5(3):248-52. PMID: 24665349; PMCID: PMC3963082; DOI: 10.7150/jca.8541;

Szalat R, Pirault J, Fermand JP, Carrié A, Saint-Charles F, Olivier M, Robillard P, Frisdal E, Villard EF, Cathébras P, Bruckert E, Chapman MJ, Giral P, Guerin M, Lesnik P, Le Goff W. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. J Intern Med. 2014 Sep; 276(3):269-84. PMID: 24428816

Leleu X, Fouquet G, Hebraud B, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Stoppa AM, Garciaz S, Touzeau C, Chaleteix C, Fermand JP, Loiseau HA, Facon T, Attal M, Moreau P. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma. Leukemia. 2013 Nov; 27(11):2242-4. PMID: 23558525

Delyon J, Bezier M, Cordoliani F, Malphettes M, Szalat R, Bagot M, Rybojad M. [Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy]. Ann Dermatol Venereol. 2013 Jan; 140(1):30-5. PMID: 23328357

Szalat R, Arnulf B, Karlin L, Rybojad M, Asli B, Malphettes M, Galicier L, Vignon-Pennamen MD, Harel S, Cordoliani F, Fuzibet JG, Oksenhendler E, Clauvel JP, Brouet JC, Fermand JP. Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. Blood. 2011 Oct 06; 118(14):3777-84. PMID: 21757618

Szalat R, Ghillani-Dalbin P, Jallouli M, Amoura Z, Musset L, Cacoub P, Sène D. Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature. Autoimmun Rev. 2010 Aug; 9(10):652-6. PMID: 20457279

Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S, Doan S, Szalat R, Baumann N, Alexandra JF, Lavallée P, Klein I, Vuillemet F, Sedel F, Sacré K, Samson Y, Roullet E, Papo T. Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract. 2009 Nov; 63(11):1663-7. PMID: 19832823; DOI: 10.1111/j.1742-1241.2009.02115.x;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 54 publications over 16 distinct years, with a maximum of 7 publications in 2021

Bar chart showing 54 publications over 16 distinct years, with a maximum of 7 publications in 2021

Year	Publications
2009	1
2010	1
2011	1
2012	1
2013	1
2014	3
2015	4
2016	6
2017	6
2018	6
2019	4
2020	3
2021	7
2022	4
2023	3
2024	3

2021-2022 International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Resear

2016-2017 NIH grant (4P50CA100707-14) to investigate the impact of bone marrow microenvironment on multiple my

2013-2014 French foundation for the research on multiple myeloma and gammopathies award

2010 Paris University: Medical thesis Congratulated with Distinctions and Silver Medal, Xanthomatosis and Monoclonal Immuno

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Monoclonal Gammopathy of clinical significance
Multiple Myeloma
Plasma cell disorder
MGUS
Genomics
Epigenomics

Available to Mentor as: (Review Mentor Role Definitions):

Advisor
Education Mentor
Project Mentor
Research / Scholarly Mentor
Work / Life Integration Mentor

Contact for Mentoring:

Email (see 'Contact Info')

650 Albany St
Boston MA 02118
Google Map

617.638.7518

Download vCard

Szalat's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (240) concept(s)

Co-Authors

See all (25) people

Similar People

See all (60) people

Same Department

Search Department